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Diabetes and obesity are two of the most significant public health 
issues of our day, and both are major epidemics in the United States 
and abroad. These conditions are inter  related; obesity has been long 
recognized as a common precursor to adult-onset (type 2) diabetes, 
although “adult-onset” is becoming an outdated term. In the United 
States, the prevalence of obesity among children and adolescents has 
almost tripled since 1980, and an estimated 12.5 million children and 
adolescents (16.9%) are considered obese (Ogden and Carroll 2010). 
This trend is also apparent in preschool children 2–5 years of age, a 
group in which obesity increased from 5% in 1976–1980 to 10.4% 
in 2007–2008 (Ogden and Carroll 2010). One report based on well-
child visits at a health maintenance organization in Massachusetts 
was particularly disturbing: The prevalence of over  weight in infants 
0–6 months of age almost doubled between 1980 and 2001, from 
3.4% to 5.9% (Kim et al. 2006). This finding suggests that factors 
other than changes in physical activity or diet are contributing to these 
trends, pointing to possible changes in fetal programming. 
The most recent estimates of diabetes prevalence in the United 
States are equally staggering. Based on data from 2005 through 2008, 
25.6 million (11.3%) of all people in the United States ≥ 20 years 
of age have diagnosed or undiagnosed diabetes (Centers for Disease 
Control and Prevention 2011). Another 35% have pre  diabetes, a 
condition in which blood glucose is higher than normal but not high 
enough to be classified as diabetes. People with pre  diabetes have an 
increased risk of developing type 2 diabetes, heart disease, and stroke.
Being overweight or obese has been estimated to account for 
approximately 70% of the cases of type 2 diabetes (Eyre et al. 2004). 
However, the etiology of the remaining 30% is unknown. Given the 
sheer numbers of people with the disease—now estimated globally 
at 220 million and expected to grow to 366 million by 2030 (World 
Health Organization 2011)—it is easy to understand the growing 
consideration of “non  traditional” risk factors (e.g., environ  mental 
chemicals, stress, micro  biome) as contributors to these diseases. A 
growing scientific literature implicating a role for environmental 
chemical exposures has been developed largely through the funding 
of the National Institute of Environmental Health Sciences (NIEHS) 
as part of the institute’s broader interest in understanding endocrine-
related disorders and the develop  mental origins of adult disease. 
Endocrine-disrupting chemicals alter control of adipose tissue 
development and function, control of food intake, insulin sensitivity, 
glucose homeo  stasis, and lipid metabolism (Janesick and Blumberg 
2011; Nadal et al. 2009; Thayer et al. 2012). If the exposure occurs 
during develop  ment, the result could possibly be an altered “set point” 
or sensitivity for developing obesity or diabetes later in life.
Research addressing the role of environmental chemicals in dia-
betes and obesity has rapidly expanded in the past several years. Both 
the May 2010 White House Task Force on Childhood Obesity (2010) 
and the 31 March 2011 Strategic Plan for NIH Obesity Research [NIH 
(National Institutes of Health) Obesity Research Task Force 2011] 
acknowledge the growing science base in this area and cite the need to 
understand more about the role of environmental exposures as part of 
future research and prevention strategies. 
To help develop such a research strategy, the National Toxicology 
Program (NTP), with collaboration from the NIEHS intramural 
and extramural program scientists, organized a state-of-the-science 
workshop in January 2011 titled “Role of 
Environmental Chemicals in the Development 
of Diabetes and Obesity.” The technical back-
ground documents assembled for this work-
shop were extensive, totaling > 500 pages and spanning the range 
from epidemiological data to high throughput screening results. As an 
additional scientific resource, approximately 800 main findings from 
the epidemiological studies of diabetes and childhood obesity have 
been compiled into a searchable graphing software program. A diverse 
group of > 150 scientists, including toxicologists, epidemiologists, and 
bioinformaticists, as well as experts in the pathobiology of diabetes 
and obesity, attended the meeting to review the existing literature and 
shape a research strategy.
The review of the collected literature supported the plausibility of 
certain environmental chemicals acting as “obesogens” or diabeto  genic 
agents. In some cases, the conclusions were based on surprisingly con-
sistent epidemiological associations. With other chemicals or chemical 
classes, consistency was found in mechanisms of action. We have little 
appreciation for the extent to which environ  mental chemi  cal expo-
sures may be influencing obesity and diabetes rates, but it is becoming 
increasingly clear that over  nutrition and a lack of exercise are not the 
entire story.
The first of a series of articles stemming from the January 2011 
workshop appears in this issue of Environmental Health Perspectives 
(Thayer et al. 2012). Kristina Thayer, director of the NTP Office 
of Health Assessment and Translation, other NIEHS staff, and the 
workshop chair, Michael Gallo (University of Medicine and Dentistry 
of New Jersey–Robert Wood Johnson Medical School) provide an 
introduction to the topic and an orientation to the workshop and key 
outcomes. Upcoming reports will examine the influence of smoking 
during pregnancy, as well as nicotine and arsenic exposures, on diabetes 
and obesity outcomes and mechanisms. 
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Two articles in this issue of EHP represent recent syntheses of research 
on the effects of mercury exposure from fish consumption: Karagas et al. 
(2012) reviewed the emerging research on health effects of low-level expo-
sures to methyl  mercury (MeHg), and Oken et al. (2012) summarized the 
com  plexities of providing clear and uniform fish consumption advice to 
reduce MeHg exposure while balancing nutrient intake, ecologic con-
cerns, and economic issues. These two papers emerged from workshops 
convened in September 2010 and July 2011 by the Coastal Marine 
Mercury Ecosystem Research Collaborative (C-MERC) and sponsored by 
the Dartmouth Superfund Research Program and its partners. C-MERC 
brought together a group of 50 scientists and stake  holders to work jointly 
to gather and analyze existing data and to publish synthesis papers on the 
fate of mercury from its environmental sources to seafood consumers—
issues of critical importance for informing public policy. 
Mercury, particularly its organic form (MeHg), is a global contam-
inant and toxicant of major concern for humans and wildlife (Driscoll 
et al. 2007; Fitzgerald et al. 2007; Grandjean et al. 2005; Mahaffey 
et al. 2009). Mercury is third (after arsenic and lead) on the 2011 
Agency for Toxic Substances and Disease Registry (ATSDR) priority   
list of 275 hazardous substances (ATSDR 2011), which includes sub-
stances that present the most significant potential threats to human 
health in the United States. MeHg has long been known as a potent 
neuro  toxicant, particularly due to incidents of acute and high-level 
exposures (e.g., Minimata, Japan; Iraq), but neurological effects have 
been documented in island populations that consume large quan-
tities of marine mammals or seafood (Axelrad et al. 2007; Cohen 
et al. 2005; Rice 2004). Moreover, recent epidemiologic studies have 
revealed evidence of a range of health effects in adults and children 
at MeHg exposure levels lower than previously observed (Lynch et al. 
2010; Mergler et al. 2007; Oken et al. 2008). In this issue of EHP, 
Karagas et al. (2012) provide a comprehensive review of the cur-
rent scientific evidence for effects of low-level exposures to MeHg 
on birth outcomes, neuro  cognitive outcomes, the cardio  vascular sys-
tem, and immune function. The authors recommend that future   
studies investigate sex-specific effects and genetic susceptibility, and 
that they include more precise exposure indicators, outcome measures 
with mechanistic bases, and consideration of 
non  linear dose–response relation  ships. Their 
review helps to set the stage for future research 
on the human effects of low-level MeHg 
exposure.
Fish are the most important agents of MeHg exposure for humans, 
and consumption of contaminated fish is a serious public health 
concern (Mahaffey et al. 2009; Oken et al. 2005; Sunderland 2007). 
Currently, all 50 U.S. states have fish advisories for inland and coastal 
waters, and states on the Atlantic coast, as well as Alaska and Hawaii, 
have state  wide coastal advisories [U.S. Environmental Protection 
Agency (EPA) 2010]. Consumption of marine fish and shellfish is 
the primary means of human exposure to MeHg; approximately 
92% of the global fish and shellfish harvest for human consump-
tion is marine [United Nations Development Programme, United 
Nations Environment Programme (UNEP), World Bank, and World 
Resources Institute 2003], with the majority coming from coastal 
fisheries (Food and Agriculture Organization of the United Nations 
2010). Most people trying to reduce MeHg exposure risk do so 
through their choices in buying and eating seafood. Oken et al. (2012) 
discuss the wide range of trade-offs facing fish consumers and the diffi-
culties in evaluating current fish consumption advice. Consumers need 
to consider not only the contaminant concentrations in fish but also 
their nutritional value, the sustainability of the fishery, and the cost 
of different fish choices. Moreover, there is little guidance for specific 
sub  populations with different exposure risks due to factors such as age 
or baseline intake of fish. The authors recommend that fish consump-
tion advice address these multiple perspectives and provide a clear and 
simple message. Ultimately, fish consumption advice should protect 
public health on a global scale and promote sustainability of the 
world’s fisheries as a critical source of human nutrition. 
Currently, important national and international policy decisions 
are being made concerning the environmental impacts of mercury. 
The widespread threat to human health posed by MeHg has prompted 
the United States to pass a mercury rule for controlling atmospheric 
emissions (U.S. EPA 2011) and the UNEP to forge a broad consensus 
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